Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Knockdown of HMGN5 Expression by RNA Interference Induces Cell Cycle Arrest in Human Lung Cancer Cells

  • Chen, Peng (Department of Respiratory Medicine, The Second Hospital of Jilin University) ;
  • Wang, Xiu-Li (Department of Hematology and Oncology, The Second Hospital of Jilin University) ;
  • Ma, Zhong-Sen (Department of Respiratory Medicine, The Second Hospital of Jilin University) ;
  • Xu, Zhong (Departments of Pediatrics, The Second Hospital of Jilin University) ;
  • Jia, Bo (Department of Medical Oncology, Chinese Academy of Medical Sciences, Cancer Institute/Hospital) ;
  • Ren, Jin (Department of Respiratory Medicine, The Second Hospital of Jilin University) ;
  • Hu, Yu-Xin (Department of Respiratory Medicine, The Second Hospital of Jilin University) ;
  • Zhang, Qing-Hua (Department of Respiratory Medicine, The Second Hospital of Jilin University) ;
  • Ma, Tian-Gang (Department of Respiratory Medicine, The Second Hospital of Jilin University) ;
  • Yan, Bing-Di (Department of Respiratory Medicine, The Second Hospital of Jilin University) ;
  • Yan, Qing-Zhu (Department of Respiratory Medicine, The Second Hospital of Jilin University) ;
  • Li, Yan-Lei (Department of Respiratory Medicine, The Second Hospital of Jilin University) ;
  • Li, Zhen (Department of Respiratory Medicine, The Second Hospital of Jilin University) ;
  • Yu, Jin-Yan (Department of Respiratory Medicine, The Second Hospital of Jilin University) ;
  • Gao, Rong (Department of Respiratory Medicine, The Second Hospital of Jilin University) ;
  • Fan, Na (Department of Respiratory Medicine, The Second Hospital of Jilin University) ;
  • Li, Bo (Department of Respiratory Medicine, The Second Hospital of Jilin University) ;
  • Yang, Jun-Ling (Department of Respiratory Medicine, The Second Hospital of Jilin University)
  • Published : 2012.07.31
Download PDF
⟨ Previous Next ⟩

Abstract

HMGN5 is a typical member of the HMGN (high mobility group nucleosome-binding protein) family which may function as a nucleosomal binding and transcriptional activating protein. Overexpression of HMGN5 has been observed in several human tumors but its role in tumorigenesis has not been fully clarified. To investigate its significance for human lung cancer progression, we successfully constructed a shRNA expression lentiviral vector in which sense and antisense sequences targeting the human HMGN5 were linked with a 9-nucleotide loop. Inhibitory effects of siRNA on endogenous HMGN5 gene expression and protein synthesis were demonstrated via real-time RT-PCR and western blotting. We found HMGN5 silencing to significantly inhibit A549 and H1299 cell proliferation assessed by MTT, BrdU incorporation and colony formation assays. Furthermore, flow cytometry analysis showed that specific knockdown of HMGN5 slowed down the cell cycle at the G0/G1 phase and decreased the populations of A549 and H1299 cells at the S and G2/M phases. Taken together, these results suggest that HMGN5 is directly involved in regulation cell proliferation in A549 and H1299 cells by influencing signaling pathways involved in cell cycle progression. Thus, our finding suggests that targeting HMGN5 may be an effective strategy for human lung cancer treatment.

Keywords

References

  1. Bates S, and Vousden KH (1996). p53 in signaling checkpoint arrest or apoptosis. Curr Opin Genet Dev, 6, 12-8. https://doi.org/10.1016/S0959-437X(96)90004-0
  2. Brummelkamp TR, Bernards R, and Agami R (2002). A system for stable expression of short interfering RNAs in mammalian cells. Science, 296, 550-3. https://doi.org/10.1126/science.1068999
  3. Bustin M (1999). Regulation of DNA-dependent activities by the functional motifs of the high-mobility-group chromosomal proteins. Mol Cell Biol, 19, 5237-46.
  4. Bustin M (2001). Chromatin unfolding and activation by HMGN($^\ast$) chromosomal proteins. Trends Biochem Sci, 26, 431-7. https://doi.org/10.1016/S0968-0004(01)01855-2
  5. Furusawa T, Lim JH, Catez F, et al (2006). Down-regulation of nucleosomal binding protein HMGN1 expression during embryogenesis modulates Sox9 expression in chondrocytes. Mol Cell Biol, 26, 592-604. https://doi.org/10.1128/MCB.26.2.592-604.2006
  6. Gerlitz G (2010). HMGNs, DNA repair and cancer. Biochim Biophys Acta, 1799, 80-5. https://doi.org/10.1016/j.bbagrm.2009.10.007
  7. Green J, Ikram M, Vyas J, et al (2006). Overexpression of the Axl tyrosine kinase receptor in cutaneous SCC-derived cell lines and tumours. Br J Cancer, 94, 1446-51. https://doi.org/10.1038/sj.bjc.6603135
  8. Hofseth LJ, Hussain SP, and Harris CC (2004). p53: 25 years after its discovery. Trends Pharmacol Sci, 25, 177-81. https://doi.org/10.1016/j.tips.2004.02.009
  9. Jemal A, Siegel R, Ward E, et al (2006). Cancer statistics, 2006. CA Cancer J Clin, 56, 106-30. https://doi.org/10.3322/canjclin.56.2.106
  10. Jiang N, Zhou LQ, and Zhang XY (2010). Downregulation of the nucleosome-binding protein 1 (NSBP1) gene can inhibit the in vitro and in vivo proliferation of prostate cancer cells. Asian J Androl, 12, 709-17. https://doi.org/10.1038/aja.2010.39
  11. Krishan A (1975). Rapid flow cytofluorometric analysis of mammalian cell cycle by propidium iodide staining. J Cell Biol, 66, 188-93. https://doi.org/10.1083/jcb.66.1.188
  12. Levine AJ (1997). p53, the cellular gatekeeper for growth and division. Cell, 88, 323-31. https://doi.org/10.1016/S0092-8674(00)81871-1
  13. Li DQ, Hou YF, Wu J, et al (2006). Gene expression profile analysis of an isogenic tumour metastasis model reveals a functional role for oncogene AF1Q in breast cancer metastasis. Eur J Cancer, 42, 3274-86. https://doi.org/10.1016/j.ejca.2006.07.008
  14. Livak KJ, and Schmittgen TD (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods, 25, 402-8. https://doi.org/10.1006/meth.2001.1262
  15. Meerbrey KL, Hu G, Kessler JD, et al (2011). The pINDUCER lentiviral toolkit for inducible RNA interference in vitro and in vivo. Proc Natl Acad Sci USA, 108, 3665-70. https://doi.org/10.1073/pnas.1019736108
  16. Minna JD, Roth JA, and Gazdar AF (2002). Focus on lung cancer. Cancer Cell, 1, 49-52. https://doi.org/10.1016/S1535-6108(02)00027-2
  17. Osada H, and Takahashi T (2002). Genetic alterations of multiple tumor suppressors and oncogenes in the carcinogenesis and progression of lung cancer. Oncogene, 21, 7421-34. https://doi.org/10.1038/sj.onc.1205802
  18. Postnikov Y, and Bustin M (2010). Regulation of chromatin structure and function by HMGN proteins. Biochim Biophys Acta, 1799, 62-8. https://doi.org/10.1016/j.bbagrm.2009.11.016
  19. Qu J, Yan R, Chen J, et al (2011). HMGN5: a potential oncogene in gliomas. J Neurooncol, 104, 729-36. https://doi.org/10.1007/s11060-011-0558-9
  20. Rochman M, Malicet C, and Bustin M (2010). HMGN5/NSBP1: a new member of the HMGN protein family that affects chromatin structure and function. Biochim Biophys Acta, 1799, 86-92. https://doi.org/10.1016/j.bbagrm.2009.09.012
  21. Rochman M, Postnikov Y, Correll S, et al (2009). The interaction of NSBP1/HMGN5 with nucleosomes in euchromatin counteracts linker histone-mediated chromatin compaction and modulates transcription. Mol Cell, 35, 642-56. https://doi.org/10.1016/j.molcel.2009.07.002
  22. Rochman M, Taher L, Kurahashi T, et al (2011). Effects of HMGN variants on the cellular transcription profile. Nucleic Acids Res, 39, 4076-87. https://doi.org/10.1093/nar/gkq1343
  23. Rubinson DA, Dillon CP, Kwiatkowski AV, et al (2003). A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nat Genet, 33, 401-6. https://doi.org/10.1038/ng1117
  24. Shirakawa H, Landsman D, Postnikov YV, et al (2000). NBP-45, a novel nucleosomal binding protein with a tissue-specific and developmentally regulated expression. J Biol Chem, 275, 6368-74. https://doi.org/10.1074/jbc.275.9.6368
  25. Spiro SG, and Silvestri GA (2005). One hundred years of lung cancer. Am J Respir Crit Care Med, 172, 523-9. https://doi.org/10.1164/rccm.200504-531OE
  26. Ueda T, Furusawa T, Kurahashi T, et al (2009). The nucleosome binding protein HMGN3 modulates the transcription profile of pancreatic beta cells and affects insulin secretion. Mol Cell Biol, 29, 5264-76. https://doi.org/10.1128/MCB.00526-09
  27. Zhu N, and Hansen U (2007). HMGN1 modulates estrogen-mediated transcriptional activation through interactions with specific DNA-binding transcription factors. Mol Cell Biol, 27, 8859-73. https://doi.org/10.1128/MCB.01724-07
  28. Zhu N, and Hansen U (2010). Transcriptional regulation by HMGN proteins. Biochim Biophys Acta, 1799, 74-9. https://doi.org/10.1016/j.bbagrm.2009.11.006

Cited by

  1. Suppression of nucleosome-binding protein 1 by miR-326 impedes cell proliferation and invasion in non-small cell lung cancer cells vol.35, pp.2, 2015, https://doi.org/10.3892/or.2015.4403
  2. Research advances in HMGN5 and cancer vol.37, pp.2, 2016, https://doi.org/10.1007/s13277-015-4693-3
  3. Overexpression of microRNA-495 suppresses the proliferation and invasion and induces the apoptosis of osteosarcoma cells by targeting high-mobility group nucleosome-binding domain 5 vol.38, pp.2, 2017, https://doi.org/10.3892/or.2017.5715